Key facts
- It has raised $109.7M; the latest was Later Stage VC ($49.4M) in Jul 2024.
- Notable investors include SPRIM Global Investments, Tikehau Capital, Ayala (Makati), Dedalus, Guardant Health — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for ObvioHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for ObvioHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ObvioHealth
Developer of a clinical research platform designed to tackle the inefficiencies in the trial process. The company's platform delivers better data to sponsors and an easier clinical trial experience for participants, enabling clients to conduct virtual clinical trials and to participate in clinical trials from the comfort of their homes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 69
- Website
- obviohealth.com/
- Ownership
- Privately Held (backing)
ObvioHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ObvioHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ObvioHealth in its N-PORT filings yet. We sweep new filings monthly.